Clinical Trial: Phase 1 Trial of JTM201 in Subjects With Post-stroke Upper Limb Spasticity

U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07292025) titled 'Phase 1 Trial of JTM201 in Subjects With Post-stroke Upper Limb Spasticity' on Nov. 24.

Brief Summary: Phase 1 trial to evaluate the safety and efficacy of JTM201 compared with 'Botox(R) Inj.' in subjects with post-stroke upper limb spasticity

Study Start Date: June 29, 2023

Study Type: INTERVENTIONAL

Condition: Upper Limb Spasticity Post-Stroke

Intervention: DRUG: JTM201 in normal saline

Max 360 U of Test drug IM

DRUG: BOTOX 100U in normal saline

Max 360 U of BOTOX IM

Recruitment Status: COMPLETED

Sponsor: Jetema Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....